{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:28:46Z","timestamp":1790299726139,"version":"4.1.0"},"reference-count":23,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2008.0483","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T09:11:18Z","timestamp":1525252278000},"source":"Crossref","is-referenced-by-count":5,"title":["The Importance of Genetic Testing in the Clinical Management of Patients With Marfan Syndrome and Related Disorders"],"prefix":"10.3238","author":[{"given":"Mine","family":"Arslan-Kirchner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yskert von","family":"Kodolitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Schmidtke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2008,7,4]]},"reference":[{"key":"10.3238\/arztebl.2008.0483_ref1","unstructured":"Management of genetic syndromes, 2nd edition. Cassidy SB, Allanson JE (Hrsg.) Hoboken: Wiley-Liss 2005."},{"key":"10.3238\/arztebl.2008.0483_ref2","unstructured":"von Kodolitsch Y, Baumgart D, Eggebrecht H et al.: Das akute Aortensyndrom. Dtsch Arztebl 2003; 100(6): A 326\u201333."},{"key":"10.3238\/arztebl.2008.0483_ref3","doi-asserted-by":"crossref","unstructured":"Silvermann DI, Burton KJ, Gray J et al: Life expectancy in the Marfan syndrome. Am J Cardiol 1995; 75: 157\u201360.","DOI":"10.1016\/S0002-9149(00)80066-1"},{"key":"10.3238\/arztebl.2008.0483_ref4","unstructured":"Orphanet-Handbuch Seltene Erkrankungen. Neu-Isenburg: MMI-Verlag 2007."},{"key":"10.3238\/arztebl.2008.0483_ref5","unstructured":"WHO report on priority medicines for europe and the world. World Health Organization. WHO document WHO\/EDM\/PAR\/2004.7. Geneva 2004."},{"key":"10.3238\/arztebl.2008.0483_ref6","doi-asserted-by":"crossref","unstructured":"von Kodolitsch Y, Kuhnel P, Kreymann G, Nienaber CA: Lysis therapy in aortic dissection: by hypertrophic cardiomyopathy simulated myocardial infarct. Z Kardiol 1998; 87: 150\u201360.","DOI":"10.1007\/s003920050167"},{"key":"10.3238\/arztebl.2008.0483_ref7","doi-asserted-by":"crossref","unstructured":"von Kodolitsch Y, Rybczynski M: Cardiovascular aspects of the Marfan syndrome \u2013 A systematic review. In: Marfan syndrome: a primer for clinicians and scientists. Robinson PN, Godfrey M (Hrsg.) Hingham, MA, USA: Kluwer Academic\/Plenum Publishers, 2004; 45\u201369.","DOI":"10.1007\/978-1-4419-9013-6_5"},{"key":"10.3238\/arztebl.2008.0483_ref8","doi-asserted-by":"crossref","unstructured":"von Kodolitsch Y, Robinson PN: Marfan syndrome. An update of genetics, medical and surgical management. Heart 2007; 93: 755\u201360.","DOI":"10.1136\/hrt.2006.098798"},{"key":"10.3238\/arztebl.2008.0483_ref9","doi-asserted-by":"crossref","unstructured":"De Paepe A, Devereux RB, Dietz HC, Hennekam RCM, Pyeritz RE: Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 1996; 62: 417\u201326.","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R"},{"key":"10.3238\/arztebl.2008.0483_ref10","doi-asserted-by":"crossref","unstructured":"De Backer J, Loeys B, Leroy B, Coucke P, Dietz H, de Paepe A: Utility of molecular analyses in the exploration of extreme intrafamilial variability in the Marfan syndrome. Clin Genet 2007; 72: 188\u201398.","DOI":"10.1111\/j.1399-0004.2007.00845.x"},{"key":"10.3238\/arztebl.2008.0483_ref11","doi-asserted-by":"crossref","unstructured":"Faivre L, Collod-Beroud G, Loeys BL et al.: Contribution of molecular analyses in diagnosing Marfan syndrome and type I fibrillinopathies: an international study of 1009 probands. J Med Genet 2008; Feb 29 [Epub ahead of print]","DOI":"10.1136\/jmg.2007.056382"},{"key":"10.3238\/arztebl.2008.0483_ref12","unstructured":"The FBN1 mutations database www.umd.be:2030"},{"key":"10.3238\/arztebl.2008.0483_ref13","doi-asserted-by":"crossref","unstructured":"Matyas G, Arnold E, Carrel T et al.: Identification and in silico analyses of novel TGFBR1 and TGFBR2 mutations in Marfan syndrome- related disorders. Hum Mutat 2006; 27: 760\u20139.","DOI":"10.1002\/humu.20353"},{"key":"10.3238\/arztebl.2008.0483_ref14","doi-asserted-by":"crossref","unstructured":"Singh KK, Rommel K, Mishra A et al.: TGFBR1 and TGFBR2 mutations in patients with features of Marfan syndrome and Loeys-Dietz syndrome. Hum Mutat 2006; 27: 770\u20137.","DOI":"10.1002\/humu.20354"},{"key":"10.3238\/arztebl.2008.0483_ref15","doi-asserted-by":"crossref","unstructured":"Mizuguchi T, Collod-Beroud G, Akiyama T et al.: Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 2004; 36: 855\u201360.","DOI":"10.1038\/ng1392"},{"key":"10.3238\/arztebl.2008.0483_ref16","doi-asserted-by":"crossref","unstructured":"Loeys BL, Chen J, Neptune ER, et al.: A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005; 37: 275\u201381.","DOI":"10.1038\/ng1511"},{"key":"10.3238\/arztebl.2008.0483_ref17","doi-asserted-by":"crossref","unstructured":"Neptune ER, Frischmeyer PA, Arking DE et al.: Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nature Genet 2003; 33: 407\u201311.","DOI":"10.1038\/ng1116"},{"key":"10.3238\/arztebl.2008.0483_ref18","doi-asserted-by":"crossref","unstructured":"Ng CM, Cheng A, Myers LA et al.: TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 1586\u201392.","DOI":"10.1172\/JCI200422715"},{"key":"10.3238\/arztebl.2008.0483_ref19","doi-asserted-by":"crossref","unstructured":"Loeys BL, Schwarze U, Holm T: Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355: 788\u201398.","DOI":"10.1056\/NEJMoa055695"},{"key":"10.3238\/arztebl.2008.0483_ref20","doi-asserted-by":"crossref","unstructured":"Judge DP, Dietz HC: Therapy of Marfan Syndrome. Annu Rev Med 2007; 59: 43\u201359.","DOI":"10.1146\/annurev.med.59.103106.103801"},{"key":"10.3238\/arztebl.2008.0483_ref21","doi-asserted-by":"crossref","unstructured":"Guo DC, Pannu H, Tran-Fadulu V et al.: Mutations in smooth muscle alpha-actin (ACTA2) lead to thoracic aortic aneurysms and dissections. Nat Genet 2007; 39: 1488\u201393.","DOI":"10.1038\/ng.2007.6"},{"key":"10.3238\/arztebl.2008.0483_ref22","doi-asserted-by":"crossref","unstructured":"Faivre L, Collod-Beroud G, Loeys BL et al.: Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81: 454\u201366.","DOI":"10.1086\/520125"},{"key":"10.3238\/arztebl.2008.0483_ref23","doi-asserted-by":"crossref","unstructured":"von Kodolitsch Y, Rybczynski M, Detter C, Robinson PN: Diagnosis and management of Marfan syndrome. Future Cardiology 2008; 4: 85\u201396.","DOI":"10.2217\/14796678.4.1.85"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2008.0483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T10:05:51Z","timestamp":1638871551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2008.0483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7,4]]},"references-count":23,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2008.0483","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,7,4]]}}}